These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22570261)

  • 1. Epithelial-mesenchymal crosstalk alteration in kidney fibrosis.
    Prunotto M; Budd DC; Gabbiani G; Meier M; Formentini I; Hartmann G; Pomposiello S; Moll S
    J Pathol; 2012 Oct; 228(2):131-47. PubMed ID: 22570261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From acute injury to chronic disease: pathophysiological hypothesis of an epithelial/mesenchymal crosstalk alteration in CKD.
    Prunotto M; Budd DC; Meier M; Formentini I; Hartmann G; Pomposiello S; Moll S
    Nephrol Dial Transplant; 2012 Oct; 27 Suppl 3():iii43-50. PubMed ID: 22785113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines in epithelial-mesenchymal transition: a new insight into obstructive nephropathy.
    Bani-Hani AH; Campbell MT; Meldrum DR; Meldrum KK
    J Urol; 2008 Aug; 180(2):461-8. PubMed ID: 18550128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis.
    Rastaldi MP
    J Nephrol; 2006; 19(4):407-12. PubMed ID: 17048197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AST-120 ameliorates epithelial-to-mesenchymal transition and interstitial fibrosis in the kidneys of chronic kidney disease rats.
    Bolati D; Shimizu H; Niwa T
    J Ren Nutr; 2012 Jan; 22(1):176-80. PubMed ID: 22200438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of tubular epithelial-mesenchymal transition in progressive kidney disease.
    Burns WC; Kantharidis P; Thomas MC
    Cells Tissues Organs; 2007; 185(1-3):222-31. PubMed ID: 17587828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renoprotective properties of pirfenidone in subtotally nephrectomized rats.
    Takakuta K; Fujimori A; Chikanishi T; Tanokura A; Iwatsuki Y; Yamamoto M; Nakajima H; Okada M; Itoh H
    Eur J Pharmacol; 2010 Mar; 629(1-3):118-24. PubMed ID: 20006961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: Endothelial-myofibroblast transition, a new player in diabetic renal fibrosis.
    Li J; Bertram JF
    Nephrology (Carlton); 2010 Aug; 15(5):507-12. PubMed ID: 20649869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ultrastructure of human tubulo-interstitial fibrosis.
    Ru Y; Eyden B
    J Submicrosc Cytol Pathol; 2003 Apr; 35(2):147-60. PubMed ID: 12974328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
    Onuigbo MA
    Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD.
    Onuigbo MA
    Ren Fail; 2010; 32(8):954-8. PubMed ID: 20722563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal failure and concurrent RAAS blockade in older CKD patients with renal artery stenosis: an extended Mayo Clinic prospective 63-month experience.
    Onuigbo MA; Onuigbo NT
    Ren Fail; 2008; 30(4):363-71. PubMed ID: 18569908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actin filaments in human renal tubulo-interstitial fibrosis: significance for the concept of epithelial-myofibroblast transformation.
    Ru Y; Eyden B; Curry A; McWilliam LJ; Coyne JD
    J Submicrosc Cytol Pathol; 2003 Jul; 35(3):221-33. PubMed ID: 14690170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered regulation of renin-angiotensin, endothelin and natriuretic peptide systems in rat kidney with chronic unilateral ureteral obstruction.
    Bae EH; Kim IJ; Park JW; Ma SK; Choi KC; Lee JU; Kim SW
    Urol Int; 2007; 79(2):170-6. PubMed ID: 17851289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanisms in remodeling of the kidney].
    Nangaku M; Miyata T
    Nihon Rinsho; 2008 Sep; 66(9):1696-700. PubMed ID: 18788396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects.
    López-Hernández FJ; López-Novoa JM
    Cell Tissue Res; 2012 Jan; 347(1):141-54. PubMed ID: 22105921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E ameliorates renal fibrosis in ureteral obstruction: role of maintaining BMP-7 during epithelial-to-mesenchymal transition.
    Tasanarong A; Kongkham S; Thitiarchakul S; Eiam-Ong S
    J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S10-8. PubMed ID: 22619901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of kidney fibrosis and the role of antifibrotic therapies.
    Deelman L; Sharma K
    Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):85-90. PubMed ID: 19077695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology.
    Burns WC; Thomas MC
    Expert Rev Mol Med; 2010 May; 12():e17. PubMed ID: 20504380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.